The transcriptomics market was valued at $5,790.51 million in 2020, and is estimated to reach $11,397.08million by 2030, growing at a CAGR of 7.0% from 2021 to 2030.Transcriptomics is the collection and study of RNA present in different types of cells and tissues in an organism. It is a promising tool for discovery of basic gene expression patterns, determination of drug-induced toxicity in adverse drug reactions, and other uses in the medical field. It is an analysis of transcriptome. RNA performs many functions within the cell and studying the transcriptome provides insights into how genes are working and whether proteins are being produced.
Increase in advancements in the field of transcriptomics such as extensive use of RNA-sequencing and rise in application of transcriptomics such as drug discovery are expected to drive the growth of the market. Moreover, other factors that fuel the market growth include increase in adoption of transcriptomics products and rise in demand for personalized medicine. In addition, many companies have increased their market presence, thereby expanding their business across new markets. For instance, in February 2020, Dovetail Genomics announced the launch of its Dovetail HichlP and Micro-C kits. These aforementioned factors have led to increase in the growth of the transcriptomics market.
Furthermore, the high demand for diagnostic of inflammatory diseases such as COVID-19, and rise in production of transcriptomics instruments to boost the growth of the market. In addition, in February 2020, Caris Life Sciences launched its new MI transcriptome, which enables whole transcriptome sequencing. MI transcriptome uses the high capability of sequencing to gain insight into the RNA profiles of tumor patients. Thus, increased availability of transcriptomics instruments propels the growth of the transcriptomics market.
Conversely, high capital investment in the implementation of transcriptomics is anticipated to hinder the market growth. People, nowadays are more aware of health, which, in turn, compels them to maintain their health condition and increase demand for diagnosis of various diseases. This has further encouraged many key players to enter emerging markets, thus offering a lucrative growth opportunity in the transcriptomics market.
The global transcriptomics market is segmented on the basis of type, technology, application, and region. By Type, the market is categorized into consumables, instruments, software, and services.
On the basis of technology, the market is divided into microarrays, q PCR, and sequencing technology.
Depending on application, it is fragmented into drug discovery, diagnostics, disease profiling, and others. On the basis of end user, it is divided into government institutes & academic centers, pharmaceutical & biotechnology companies and contract research organizations. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global transcriptomics market are Agilent Technologies Inc, Bio-Rad Laboratories, F-Hoffmann La-Roche, Fluidigm Corporation, General Electric Company, Illuminia Inc., Merck & Co. Inc, Promega Corporation, QiagenInc, and ThermoFisher Scientific.
BY Application
BY End User
Increase in advancements in the field of transcriptomics such as extensive use of RNA-sequencing and rise in application of transcriptomics such as drug discovery are expected to drive the growth of the market. Moreover, other factors that fuel the market growth include increase in adoption of transcriptomics products and rise in demand for personalized medicine. In addition, many companies have increased their market presence, thereby expanding their business across new markets. For instance, in February 2020, Dovetail Genomics announced the launch of its Dovetail HichlP and Micro-C kits. These aforementioned factors have led to increase in the growth of the transcriptomics market.
Furthermore, the high demand for diagnostic of inflammatory diseases such as COVID-19, and rise in production of transcriptomics instruments to boost the growth of the market. In addition, in February 2020, Caris Life Sciences launched its new MI transcriptome, which enables whole transcriptome sequencing. MI transcriptome uses the high capability of sequencing to gain insight into the RNA profiles of tumor patients. Thus, increased availability of transcriptomics instruments propels the growth of the transcriptomics market.
Conversely, high capital investment in the implementation of transcriptomics is anticipated to hinder the market growth. People, nowadays are more aware of health, which, in turn, compels them to maintain their health condition and increase demand for diagnosis of various diseases. This has further encouraged many key players to enter emerging markets, thus offering a lucrative growth opportunity in the transcriptomics market.
The global transcriptomics market is segmented on the basis of type, technology, application, and region. By Type, the market is categorized into consumables, instruments, software, and services.
On the basis of technology, the market is divided into microarrays, q PCR, and sequencing technology.
Depending on application, it is fragmented into drug discovery, diagnostics, disease profiling, and others. On the basis of end user, it is divided into government institutes & academic centers, pharmaceutical & biotechnology companies and contract research organizations. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global transcriptomics market are Agilent Technologies Inc, Bio-Rad Laboratories, F-Hoffmann La-Roche, Fluidigm Corporation, General Electric Company, Illuminia Inc., Merck & Co. Inc, Promega Corporation, QiagenInc, and ThermoFisher Scientific.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides an extensive analysis of the current and emerging market trends and dynamics in the global transcriptomics market to identify the prevailing opportunities
- This study presents the competitive landscape of the global market to predict the competitive environment across geographies
- Comprehensive analysis of factors that drive and restrict the market growth is provided
- Region- & country-wise analysis is provided to understand the market trends and dynamics
KEY MARKET SEGMENTS
By Product& Services Type
- Consumables
- Instruments
- Software
- Services
By Technology
- Microarrays
- q PCR
- Sequencing Technology
BY Application
- Drug Discovery
- Diagnostics and Disease Profiling
- Others
BY End User
- Government Institutes & Academic Centers
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
KEY MARKET PLAYERS
- Agilent Technologies Inc
- Bio-Rad Laboratories
- F-Hoffmann La-Roche
- Fluidigm Corporation
- General Electric Company
- Illuminia Inc
- Merck & Co Inc
- Promega Corporation
- QiagenInc
- Thermofisher Scientific
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
Chapter 1 Introduction
Chapter 2 Executive Summary
Chapter 3 Market Overview
Chapter 4 Transcriptomics Market, by Technology
Chapter 5 Transcriptomics Market, by Products & Services
Chapter 6 Transcriptomics Market, by Application
Chapter 7 Transcriptomics Market, by End-user
Chapter 8 Transcriptomics Market, by Region
Chapter 9: Company Profiles
List of Tables
List of Figures
Executive Summary
According to a new report titled, “Transcriptomics Market by Type, Technology, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2021–2030, the transcriptomics market size was valued at $5,790.51 million in 2020, and is estimated to reach $11,397.08 million by 2030, growing at a CAGR of 7.0% from 2021 to 2030.Transcriptomics is the study of transcriptome, a complete set of RNA, which is known as expression profiling. Transcriptomics encompasses everything related to RNAs. It includes their expression levels, functions, locations, and degradation. Transcriptome analysis enabled the study of how gene expression changes in different organisms and has been instrumental in the understanding of human disease.
The factors that drive the growth of the transcriptomics market include advancements in technology and increase in research grants by various institutes. In addition, the potential of RNAs to act as candidate for diagnostic biomarkers and predictors of drug response are anticipated to further drive the demand for transcriptomics globally. Transcriptomics applications earlier were only confined to basic gene expression profiling and other research applications such as to study the quantity of RNA in a biological sample and gene expression. However, it is only after the streamlining of transcriptomics technologies, reduction in technology costs, and rise in awareness about transcriptomics technologies among both scientific intelligentsia and populace that other more prominent transcriptomic applications are reported.
Moreover, rise in investment in R&D owing to the genome projects is being initiated throughout the world. The UK launched GENE Consortium, a premiere whole genome sequencing program in Europe, which aimed at sequencing up to 100,000 genomes from patients with cancer, rare diseases, and their families from 11 genomic medicine centers. These aforementioned factors fuel the growth of the market. However, lack of skilled professionals impede the market growth. Conversely, presence of untapped market in emerging economies are expected to provide lucrative growth opportunities for the market.
Increased use of drug delivery and rise in genome mapping programs boost the growth of the market. In addition, surge in demand for genetic testing, increased demand for specific genes & various assay technologies, rise in genetic variation, and increased use of personalized medicine are the factors that drive the growth of the market. Thus, rise in development of transcriptomics by key players propels the growth of the market.
The global transcriptomics market is segmented on the basis of type, technology, application, and region. On the basis of type, the market is divided into consumables, instruments, software, and services.
The consumables segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to increase in number of product approvals, advancements in R&D activities in pharmaceutical & medical device industries, and surge in adoption of transcriptomics products. Depending upon technology, the market is divided into microarrays, q PCR, and sequencing technology. QPCR segment dominated the market.
Depending on application, it is fragmented into drug discovery, diagnostic & disease profiling, and others. The drug discovery segment acquired top position in the market in 2020, and this trend is expected to continue during the forecast period, owing to large number of transcriptomics products offered by key players and increase in use for drug discovery activities.
North America accounted for a majority of the global transcriptomics market share in 2020, and is anticipated to remain dominant during the forecast period. This is attributed to rise in production of transcriptomics, increase in number of approvals for transcriptomics products, presence of key players, and development in technology for healthcare in the region. Asia-Pacific is anticipated to witness lucrative growth, owing to increase in new technological advancement in the region and growth in health care expenditures.
Key Findings Of The Study
- By type, the consumables segment was the highest contributor to the market in 2020
- By technology, the q PCR segment was the highest contributor to the market in 2020
- On the basis ofapplication type, the drug discovery segment dominated the market in 2020, and is expected to continue this trend during the forecast period
- Region wise, North America garnered the largest revenue share in 2020, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period
- North America accounted for a majority of the transcriptomics market share in 2020, and is anticipated to remain dominant during the forecast period. This is attributed to rise in prevalence of inflammatory diseases, presence of key players, development of the healthcare sector, presence of numerous transcriptomics products Asia-Pacific is anticipated to witness lucrative growth, owing to increase innumber of genetic testing and improvementin healthcare infrastructure
Companies Mentioned
- Agilent Technologies Inc
- Bio-Rad Laboratories
- F-Hoffmann La-Roche
- Fluidigm Corporation
- General Electric Company
- Illuminia Inc.
- Merck & Co. Inc
- Promega Corporation
- QiagenInc
- ThermoFisherScientific.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
